Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT01032993

Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms

Sponsor: Catherine Buettner

Conditions Cramps HMG COA Reductase Inhibitor Adverse Reaction Myalgia or Myositis Nos Pain Weakness

Updated 9 times since 2017 Last updated: Nov 29, 2016 Started: Dec 31, 2009 Primary completion: May 31, 2016 Completion: May 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Cramps and HMG COA Reductase Inhibitor Adverse Reaction and is currently completed. Catherine Buettner leads this study, which shows 9 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2023 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Dec 2022 — Jan 2023 [monthly]

Completed PHASE2_PHASE3
Dec 2021 — Dec 2022 [monthly]

Completed PHASE2_PHASE3

▶ Show 4 earlier versions

Jan 2021 — Dec 2021 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

Status: Active Not Recruiting → Completed
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting PHASE2_PHASE3

First recorded

Dec 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Catherine Buettner
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Data source: Beth Israel Deaconess Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States